⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AMRX News
Amneal Pharmaceuticals, Inc. Class A Common Stock
Dyspnea Treatment Market 2026-2031 - Rising Prevalence of Respiratory and Cardiovascular Diseases to Drive Growth
globenewswire.com
PFE
AZN
TEVA
AMRX
BHC
Babesiosis Treatment 2026-2031 - Rising Incidence of Tick-Borne Diseases Drives Market Growth
globenewswire.com
AMRX
GSK
PFE
VTRS
Form 8-K
sec.gov
AMRX
Form 8-K
sec.gov
AMRX
Form 8-K
sec.gov
AMRX
Form 8-K
sec.gov
AMRX
Amneal Reports Second Quarter 2026 Financial Results
globenewswire.com
AMRX
Kaskela Law LLC Announces Investigation of Amneal Pharmaceuticals, Inc. (AMRX) and Encourages AMRX Shareholders to Contact the Firm
businesswire.com
AMRX
Amneal Expands Iohexol Injection Portfolio with U.S. FDA Approval of Additional Strengths and Presentations
globenewswire.com
AMRX
The Alzheimer's Drug Discovery Foundation and The Michael J. Fox Foundation Launch $5 Million Partnership to Target Key Co-Pathologies Driving Alzheimer's and Parkinson's
prnewswire.com
AMRX